Myelinating Schwann cells and Netrin-1 control intra-nervous vascularization of the developing mouse sciatic nerve

Archive ouverte

Taïb, Sonia | Lamandé, Noël | Martin, Sabrina | Coulpier, Fanny | Topilko, Piotr | Brunet, Isabelle

Edité par CCSD ; eLife Sciences Publication -

International audience. Peripheral nerves are vascularized by a dense network of blood vessels to guarantee their complex function. Despite the crucial role of vascularization to ensure nerve homeostasis and regeneration, the mechanisms governing nerve invasion by blood vessels remain poorly understood. We found, in mice, that the sciatic nerve invasion by blood vessels begins around embryonic day 16 and continues until birth. Interestingly, intra-nervous blood vessel density significantly decreases during post-natal period, starting from P10. We show that, while the axon guidance molecule Netrin-1 promotes nerve invasion by blood vessels via the endothelial receptor UNC5B during embryogenesis, myelinated Schwann cells negatively control intra-nervous vascularization during post-natal period.

Suggestions

Du même auteur

Vascular dysfunction is at the onset of oxaliplatin-induced peripheral neuropathy symptoms in mice

Archive ouverte | Taïb, Sonia | CCSD

International audience. Oxaliplatin-induced peripheral neuropathy (OIPN) is an adverse side effect of this chemotherapy used for gastrointestinal cancers. The continuous pain experienced by OIPN patients often resul...

Interaction Between ALK1 Signaling and Connexin40 in the Development of Arteriovenous MalformationsSignificance

Archive ouverte | Gkatzis, Konstantinos | CCSD

International audience

Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2

Archive ouverte | Thalgott, Jérémy | CCSD

International audience. Background: Hereditary Hemorrhagic Telangiectasia type 2 (HHT2) is an inherited genetic disorder characterized by vascular malformations and hemorrhage. HHT2 results from ACVRL1 haploinsuffic...

Chargement des enrichissements...